EP Patent

EP1968548A2 — Mometasone compositions and methods of making and using the same

Assigned to Perrigo Pharma International DAC · Expires 2008-09-17 · 18y expired

What this patent protects

The present invention is directed to mometasone furoate compositions comprising mometasone furoate and at least one surface stabilizer. The mometasone furoate particles of the composition preferably have an effective average particle size of less than about 2000 nm.

USPTO Abstract

The present invention is directed to mometasone furoate compositions comprising mometasone furoate and at least one surface stabilizer. The mometasone furoate particles of the composition preferably have an effective average particle size of less than about 2000 nm.

Drugs covered by this patent

Patent Metadata

Patent number
EP1968548A2
Jurisdiction
EP
Classification
—
Expires
2008-09-17
Drug substance claim
No
Drug product claim
No
Assignee
Perrigo Pharma International DAC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.